Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Our DVAX is looking great up almost $2 right now
I believe DVAX is about to have a good run..
I dare those shorties to short this one especially the FDA is most likely approved their Heplisav-B.. They'll be too dumb if they do and it will be too risky for them..
Loving the gain today.. Looking for $25 before November 9 or 10..
Looking good to kickoff this week.. 1 day down 3 days to go..
GO DVAX!
I cant wait til Monday..
Lets get KERX thing rolling and add a few more dollars in our personal investments..
Could be a very good week for my portfolio this week..
KERX FDA approval on Monday and DVAX on Thursday..
I am looking forward to Nov 9th.. Lets get this thing rolling and add a few more dollars in our personal investments..
Could be a very good week for my portfolio this week..
KERX FDA approval on Monday and DVAX on Thursday..
What gives? All of sudden up almost 10%... Leakage about being approved maybe? Either or I like it..
Ok I am back in at $2.02..I think this should be easy money from my buy in but what do I know..
Lets GO CLNE!
Dynavax beats by $0.09, misses on revenue
Nov. 3, 2017 6:40 AM ET|About: Dynavax Technologies Co... (DVAX)
|By: Niloofer Shaikh, SA News Editor
Dynavax (NASDAQ:DVAX): Q3 EPS of -$0.38 beats by $0.09.
Revenue of $0.05M (-68.8% Y/Y) misses by $0.17M.
Damn starts to trade like crap..
Uh oh I knew I should of waited :(
Ok H2R I finally took my initial position just 800 shares tho..
Hoping this will run from where I bought before and after the PDUFA..
I think I've done decent as far as my stocks this year except UNXL the stock that I thought it will do well long term.. Up to now I am shaking my head believing all the BS PRs they had put out and I really didn't see the bankruptcy coming but oh well lesson learned..
And of course if you want to diversify your portfolio I suggest you look into WPRT.. This company has been beat up but their fins for the last 3Q has been improving nicely and they are due to report next week.. My cost basis is $1.40 and bought some for my kids acct at $2.30s.. IMO WPRT still cheap and worth holding on for a long term play..
They also have a nice AH news.. again do your own DD
Good luck with your investments!
Up big AH 0.43(12.43%)
This is great news..
Westport Fuel Systems Awarded NAFTAL Tender
BRC Gas Equipment to supply 40,000 LPG systems in Algeria
VANCOUVER, British Columbia, Oct. 31, 2017 (GLOBE NEWSWIRE) -- Westport Fuel Systems Inc. (“Westport Fuel Systems”) (TSX:WPRT) (Nasdaq:WPRT) announced today that BRC Gas Equipment (“BRC”) was awarded a competitive tender bid by Algeria’s National Company for Petroleum Products Marketing and Distribution (“NAFTAL”) to supply 40,000 liquid petroleum gas (“LPG”) sequential injection systems to be delivered into the growing Algerian market in 2018.
“This is the largest tender we have received from NAFTAL to date, proving the competitiveness and quality of BRC LPG systems,” said Andrea Alghisi, Westport Fuel Systems Chief Operating Officer, Automotive. “We are pleased to be the preferred partner of NAFTAL to support their strategic program for the expansion of LPG use in one of the world’s most promising alternative fuel markets.”
Since 2002, BRC has been awarded multiple tenders from NAFTAL for a combined total of 65,000 LPG systems. With the addition of this recent tender mentioned above, a total of 105,000 LPG systems will be delivered to NAFTAL by end of 2018.
According to NAFTAL statistics, Algeria has close to 260,000 LPG vehicles or about 8% of the total passenger cars making it the largest population of LPG vehicles in Africa.
About NAFTAL
NAFTAL is an Algerian subsidiary of Sonatrach Group, which is ranked among the top 15 oil companies in the world. Specializing in the distribution of petroleum products, NAFTAL is the first company in Africa that has embarked on the conversion of gasoline engines to LPG, since the 1980s. Currently, Algeria has close to 260,000 LPG vehicles and this figure is expected to increase to 1,000,000 vehicles in 2025 as the Algerian government works to reduce the consumption of polluting fuels and promote clean fuels.
About BRC
BRC Gas Equipment is a well-established brand owned by Westport Fuel Systems Inc. with sole distributors in more than 70 countries and an extensive network of installation centres. Based in Cherasco, Italy, BRC Gas Equipment develops, manufactures and markets components and systems for converting vehicles from petrol to LPG and compressed natural gas.
About Westport Fuel Systems
At Westport Fuel Systems, we are driving innovation to power a cleaner tomorrow. We are inventors, engineers, manufacturers and suppliers of advanced clean-burning fuel systems and components that can change the way the world moves. Our technology delivers performance, fuel efficiency and environmental benefits to address the challenges of global climate change and urban air quality. Headquartered in Vancouver, Canada, we serve our customers in more than 70 countries with leading global transportation brands. At Westport Fuel Systems, we think ahead. For more information, visit www.wfsinc.com.
Note: This document contains forward-looking statements. Forward-looking information is typically identified by words such as “anticipate”, “estimate”, “expect”, “forecast”, “may”, “will”, “could”, “plan”, “intend”, “should”, “believe”, “outlook”, “project”, “potential”, “target” and similar words suggesting future events or future performance. In particular, this press release contains forward-looking information which includes statements regarding the delivery of injection systems and expected revenue from the discussed tender bid, demand for our products, the future success of our business and technology strategies, intentions of partners and potential customers, the performance and competitiveness of our products and expansion of product coverage and future market opportunities. These statements are neither promises nor guarantees, but involve known and unknown risks and uncertainties and are based on assumptions that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activities, performance or achievements expressed in or implied by these forward looking statements. These risks and assumptions include risks and assumptions related to our revenue growth, operating results, industry and products, the general economy, conditions of and access to the capital and debt markets, governmental policies and regulation, technology innovations, fluctuations in foreign exchange rates, the availability and price of natural gas, global government stimulus packages, the acceptance of and shift to natural gas vehicles in fleet markets, the development of competing technologies as well as other risk factors and assumptions that may affect our actual results, performance or achievements or financial position discussed in our most recent Annual Information Form and other filings with securities regulators. Readers should not place undue reliance on any such forward-looking statements, which speak only as of the date they were made. We disclaim any obligation to publicly update or revise such statements to reflect any change in our expectations or in events, conditions or circumstances on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward- looking statements except as required by National Instrument 51-102. The contents of any website, RSS feed or Twitter account referenced in this press release are not incorporated by reference herein.
Inquiries:
Caroline Sawamoto
Manager, Investor Relations & Communications
Westport Fuel Systems
T: +1 604-718-2046
invest@wfsinc.com
You seem to like the BP stocks so I want you to put DVAX on your radar.. Their Heplisav_B vaccine for hepatitis is about to get approved no later than Nov 10th..I have a pretty good position on DVAX.. My initial position from my 401K I bought it around $7s and my Ameriturd account I bought it around $10s.. I've done well so far but things will only get better and I am looking at around mid $30s next year.. Of course all in my opinion do your DD..
Good luck in your investment..
Thanks H2R! I might take position on KERX before Nov 6..
Btw do you still have AGEN?
Thank GOD no.. I was trading it last year but never invested long term..
I recently bought at the low $2s and sold when it went to $5.60..
Now I am back at $3.36
Not a whole lot happening to CRRVF these days..
I expect pps to trade in this range but should be exciting in the upcoming year..
Would like to join you and the others who probably own 100k+ shares whatworld but only if DVAX get FDA approved of their Heplisav-B vaccine ( a 99% chance it will get approved ) on or before Nov 10th..
Else I am happy with over 50k shares in hand..
Me too but my enrty is $3.36 still not bad tho...
I expect the volume and pps to pick up heading into Nov 10th FDA approval.. Maybe today is the beginning of nice a run..
Need less than 3k to match the shares that I own..
4 yrs ago 50k volume was considered a good one..lol
Back in the low $3s hope MNKD turned its corner..
To this day AGEN is prolly the most disappointed biotech I've ever own.. How on earth can you explain about getting their shingrix approved by the FDA and pps go down to the shitter?
I am going have patience just becuz I still have hope that AGEN will be like EXEL when I rode from high $3s and sold at $21s in a short period of time..
Heard anything from IR yet?
Well the stock is getting beat up like a drum again.. I am still SMH how this went down on a FDA approval first time I've seen a biotech like that..
I am truly disappointed that pps is not even close to $5...
Expected!!
Definitely awesome news!! This will bring nice $$ into the company
In a fantasy world I would say $30 but I would be happy if it hits $3 by end of next year..
Awesome H2R! Promise you are not going to be disappointed :)
Good luck to you..
Will do some DD on your stocks when I get a chance.. thanks for the heads up..
Btw
Holding over 50k shares on ARTH including 5k shares on both of my kids acct..
Good luck if you get some..
Yes AGEN recovered nicely but I think its because investors know the FDA approval are week(s)or days away..
H2R when you get a chance do DD on ARTH just waiting for 510 pending approval from the FDA..
Been invested in ARTH for 4yrs and was lucky bought most of my shares at 0.1775 and 0.19 and things are progressing..
Good luck to you too H2R..
Dynavax launches study to identify the best dose of inhaled DV281 for combo study with PD-1 inhibitor in lung cancer
Oct. 19, 2017 11:26 AM ET|About: Dynavax Technologies C... (DVAX)|By: Douglas W. House, SA News Editor
•Dynavax (DVAX +1.7%) initiates a 24-subject, open-label Phase 1b dose escalation study to identify the optimum dose of inhaled toll-like receptor 9 (TLR9) agonist DV281 in patients with non-small cell lung cancer (NSCLC). The most effective dose will be used in an expansion phase where it will be evaluated with a PD-1 inhibitor (e.g., Merck's Keytruda).
•The company says it specifically formulated DV281 for inhalation to facilitate the delivery of a TLR9 agonist to lung tumors, not easily accessible via intratumoral injection.
Oh boy dilution! didn't see this coming..
Thanks for posting it BD..
Their PR department are prolly done crossing the T's and dotting the I's just waiting for Norchi to give them the go sign..
Preparing to blastoff..
And vice versa..
Nice mover today..
No doubt this is a great deal for PLX..
Glad did not sell my kids shares.. patience really pays..
The traders can do whatever the hell they want to do Joe it doesn't affect me..I am long and I am eyeing on the November 10th FDA's decision and beyond..